Clinical Trials Directory

Trials / Completed

CompletedNCT01368705

Nitrogen Balance in Infants After Post Cardiothoracic Surgery

Determination of Protein Needs Using Nitrogen Balance in Infants Immediately Post Cardiothoracic Surgery

Status
Completed
Phase
Phase 4
Study type
Interventional
Enrollment
24 (actual)
Sponsor
The Hospital for Sick Children · Academic / Other
Sex
All
Age
1 Day – 12 Months
Healthy volunteers
Not accepted

Summary

The objective is to the amount of protein infants require after cardiopulmonary bypass surgery.

Detailed description

Postoperative neonates are susceptible to the adverse effects of surgery that is characterized by a breakdown of body stores. Without appropriate nutritional consideration this process can lead to increased physiological instability. It has been extensively documented that critically ill patients are typically catabolic. This results in body nitrogen losses from the breakdown of somatic protein to fuel metabolic processes such as, gluconeogenesis. The evaluation of this catabolic response is particularly crucial in infants due to their limited fat and lean body mass reserves. Quantifying the amount of protein needed to maintain body composition and to meet the demands of surgical stress is of clinical importance when considering factors associated with postoperative morbidity, such as delayed wound healing, impaired growth and prolonged hospital stay. The results obtained from this study will assist with determining an appropriate level of protein for the development of optimal nutrition prescriptions that are aimed at reducing catabolism of body stores.

Conditions

Interventions

TypeNameDescription
DIETARY_SUPPLEMENTStandard protein deliveryProtein delivery of 1.5 g/kg/day.
DIETARY_SUPPLEMENTIntervention 1 (2.2g/kg/day)protein delivery of 2.2g/kg/day
DIETARY_SUPPLEMENTIntervention 2 (3.0 g/kg/day)protein delivery of 3.0 g/kg/day

Timeline

Start date
2009-08-01
Primary completion
2012-06-01
Completion
2012-06-01
First posted
2011-06-08
Last updated
2013-08-19

Locations

1 site across 1 country: Canada

Source: ClinicalTrials.gov record NCT01368705. Inclusion in this directory is not an endorsement.